254 related articles for article (PubMed ID: 35178842)
1. m
Zhou L; Gao G; Tang R; Wang W; Wang Y; Tian S; Qin G
Plant Biotechnol J; 2022 Aug; 20(8):1447-1455. PubMed ID: 35178842
[TBL] [Abstract][Full Text] [Related]
2. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
4. Epitranscriptomics: An Additional Regulatory Layer in Plants' Development and Stress Response.
Shoaib Y; Usman B; Kang H; Jung KH
Plants (Basel); 2022 Apr; 11(8):. PubMed ID: 35448761
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
6. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits FTO demethylase activity to regulate N
Kuschman HP; Palczewski MB; Hoffman B; Menhart M; Wang X; Glynn S; Islam ABMMK; Benevolenskaya EV; Thomas DD
Redox Biol; 2023 Nov; 67():102928. PubMed ID: 37866163
[TBL] [Abstract][Full Text] [Related]
8. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
10. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
Yue Y; Liu J; He C
Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
[TBL] [Abstract][Full Text] [Related]
12. Leptin Reduces Plin5 m
Wei D; Sun Q; Li Y; Li C; Li X; Sun C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638947
[TBL] [Abstract][Full Text] [Related]
13. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
Meyer KD; Jaffrey SR
Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
[TBL] [Abstract][Full Text] [Related]
14. Dynamic m6A modification regulates local translation of mRNA in axons.
Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
16. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Shan HJ; Gu WX; Duan G; Chen HL
Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
[TBL] [Abstract][Full Text] [Related]
17. m
Xia Z; Xu J; Lu E; He W; Deng S; Gong AY; Strass-Soukup J; Martins GA; Lu G; Chen XM
Front Immunol; 2021; 12():705232. PubMed ID: 34295340
[TBL] [Abstract][Full Text] [Related]
18. N
Zhou J; Wan J; Shu XE; Mao Y; Liu XM; Yuan X; Zhang X; Hess ME; Brüning JC; Qian SB
Mol Cell; 2018 Feb; 69(4):636-647.e7. PubMed ID: 29429926
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
[TBL] [Abstract][Full Text] [Related]
20. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
Zhao Z; Meng J; Su R; Zhang J; Chen J; Ma X; Xia Q
J Hepatol; 2020 Sep; 73(3):664-679. PubMed ID: 32330603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
